Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common side effects of Wegovy (semaglutide), and many people want to know which laxative is safest to use alongside it. The short answer: osmotic laxatives such as macrogol (e.g. Movicol) are generally considered the gentlest first choice, because they work by drawing water into the bowel rather than stimulating it forcefully. Bulk-forming laxatives like ispaghula husk (Fybogel) are a close second, provided you drink enough fluid. What works for you, though, depends on your own health picture — and it is worth running any new medicine or supplement past your prescriber or pharmacist before starting it alongside a prescription treatment like Wegovy. Wegovy is a prescription-only medicine; a clinician decides whether it is right for you based on a full assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before adding any medicine to the mix, it helps to understand why Wegovy slows things down. Semaglutide reduces how quickly food leaves your stomach, which is part of why it curbs appetite so effectively. The knock-on effect is slower transit through the whole digestive tract. On top of that, most people eat noticeably less when they start treatment, so there is simply less bulk for the bowel to move along.
The first practical steps are straightforward. Aim for at least 1.5–2 litres of water a day, more if you have had any nausea or vomiting. Add fibre gradually: vegetables, fruit, oats and pulses all help, though going too fast can cause bloating. Light movement, even a 20-minute walk, encourages bowel motility in a way that sitting still does not. The NHS medicines page for semaglutide lists constipation among the common side effects and recommends these same lifestyle measures as the first port of call.
Give these adjustments a few days. Many people find the constipation settles as their body adapts to the new dose, it tends to be most noticeable in the first week or two after starting or after a dose increase.
If dietary and fluid changes have not helped after three to four days, a laxative is reasonable. The type matters.
Osmotic laxatives (macrogol (Movicol, Laxido) and lactulose) draw water into the large bowel to soften stools. Macrogol is usually preferred to lactulose because it tends to cause less bloating. These are widely available from pharmacies without a prescription and are generally well tolerated alongside Wegovy.
Bulk-forming laxatives (ispaghula husk (Fybogel) or methylcellulose) absorb water and expand in the bowel, making stools easier to pass. They work over two to three days rather than overnight. The catch: they require adequate fluid intake to work properly. If you are already struggling to drink enough, an osmotic laxative may be the better starting point.
Stimulant laxatives (senna, bisacodyl) make the bowel contract more actively. They are effective but are recommended only for short-term use; regular reliance on them can reduce the bowel's natural function over time. They are a reasonable option if osmotic or bulk-forming laxatives have not shifted things, but they are not a first choice for ongoing use during Wegovy treatment.
Suppositories and enemas, glycerol suppositories are safe and fast-acting for short-term relief, and worth knowing about as an option if oral laxatives are not working quickly enough. A pharmacist can advise on suitability.
There is broader guidance on how semaglutide interacts with the body on our semaglutide overview page, and if you are curious about other things to avoid or approach carefully during treatment, the guide to what not to take with Wegovy covers interactions in more detail.
Most Wegovy-related constipation is inconvenient rather than dangerous. A few situations call for medical attention rather than another laxative.
Severe stomach pain (especially pain that is persistent and spreads towards your back) should not be attributed to constipation without a clinician ruling out other causes. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines noted acute pancreatitis as a known, if infrequent, side effect; the hallmark symptom is exactly that kind of persistent, radiating abdominal pain, sometimes with vomiting. If that describes what you are feeling, seek medical help the same day rather than waiting.
Other reasons to contact your GP or prescriber: constipation lasting more than two weeks despite laxatives, blood in your stool, significant abdominal bloating with pain, or if you are becoming noticeably dehydrated because nausea and vomiting are stopping you drinking. Dehydration puts pressure on your kidneys and can make other side effects worse.
You can report any suspected side effects of Wegovy directly to the MHRA via the Yellow Card scheme, it takes about five minutes and helps the regulator build its picture of how these medicines perform in the real population.
Questions about your specific situation (whether a particular laxative is suitable given your other medicines, how long to try one before switching, or whether your symptoms suggest something else) are exactly the kind of thing to bring to a prescriber. Our page on taking laxatives on semaglutide goes further into the clinical considerations if you want more detail before speaking to someone.
A question our prescribers hear fairly often is whether to take a laxative at the same time as Wegovy. Because Wegovy is a subcutaneous injection rather than an oral medicine, there is no absorption interaction to worry about in the way there might be with tablets. You do not need to space them apart for pharmacological reasons. Take the laxative whenever it works for your routine, most bulk-forming ones are best with meals, and macrogol sachets are easy to dissolve in a glass of water at any point in the day.
If your Wegovy injection day tends to fall at a hectic point in the week (say, a Monday when everything else is already busy, or right before a bank holiday) it is worth having a laxative on hand rather than waiting until discomfort becomes urgent. Planning a week ahead costs nothing. For information on timing your injection itself, the guide on the best time to take Wegovy has practical advice on fitting it into your week, and if you want to think through what the best time to take Wegovy really means for your daily routine, that page also explores how personal schedules affect the choice, while our separate resource on what time of day is best to take Wegovy breaks down the morning-versus-evening question in more detail.
If you are considering starting Wegovy and want to understand the full picture (side effects, suitability and what clinical supervision looks like) start your free consultation with our prescribers and get a same-day clinical review from a real clinician, not a questionnaire algorithm.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.